Overall survival with adjuvant zoledronic acid in patients with premenopausal breast cancer with complete endocrine blockade: Long-term results from ABCSG-12.
M. Gnant
Consultant or Advisory Role - AstraZeneca; Novartis; Pfizer
Honoraria - Amgen; AstraZeneca; Novartis; Pfizer; Roche; Sanofi ; Schering-Plough
Research Funding - AstraZeneca; Novartis; Pfizer
B. Mlineritsch
Honoraria - AstraZeneca; Cephalon; Novartis; Pfizer; Roche; Sanofi
H. Stoeger
Honoraria - GlaxoSmithKline; Novartis; Roche; Sanofi
G. Luschin-Ebengreuth
Honoraria - AstraZeneca; Novartis
S. Poestlberger
Honoraria - AstraZeneca; Novartis
P. C. Dubsky
Honoraria - AstraZeneca; Novartis
R. Jakesz
Consultant or Advisory Role - AstraZeneca; Roche; Sanofi
Honoraria - AstraZeneca; Roche; Sanofi
C. F. Singer
Honoraria - AstraZeneca; Novartis
Research Funding - Amgen
H. Eidtmann
Honoraria - AstraZeneca; Novartis
R. Greil
Consultant or Advisory Role - AstraZeneca; Novartis
Honoraria - AstraZeneca; Novartis